UNC Cancer Hospital - Chapel Hill, North Carolina

UNC Cancer Hospital

Chapel Hill, North Carolina 27514

We've found

2 trials

at this facility

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Chapel Hill, NC

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Chapel Hill, NC

Use our guide to learn which trials are right for you!